These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12623764)

  • 21. Hormonal changes in menopause and implications on sexual health.
    Schwenkhagen A
    J Sex Med; 2007 Mar; 4 Suppl 3():220-6. PubMed ID: 17394594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA; Simon JA; Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen replacement for women.
    Basson R
    Can Fam Physician; 1999 Sep; 45():2100-7. PubMed ID: 10509222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of androgens in hormone replacement therapy.
    Johnson CE; Berman JR
    Expert Opin Pharmacother; 2005 Sep; 6(11):1815-31. PubMed ID: 16144503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen therapy in women: for whom and when.
    Pluchino N; Carmignani A; Cubeddu A; Santoro A; Cela V; Errasti T
    Arch Gynecol Obstet; 2013 Oct; 288(4):731-7. PubMed ID: 23912530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
    Miller KK; Biller BM; Beauregard C; Lipman JG; Jones J; Schoenfeld D; Sherman JC; Swearingen B; Loeffler J; Klibanski A
    J Clin Endocrinol Metab; 2006 May; 91(5):1683-90. PubMed ID: 16478814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause.
    Sherwin BB; Gelfand MM; Brender W
    Psychosom Med; 1985; 47(4):339-51. PubMed ID: 4023162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgens and sexual behaviour in women using oral contraceptives.
    Bancroft J; Davidson DW; Warner P; Tyrer G
    Clin Endocrinol (Oxf); 1980 Apr; 12(4):327-40. PubMed ID: 6991164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic use of androgens in women.
    Davis SR
    J Steroid Biochem Mol Biol; 1999; 69(1-6):177-84. PubMed ID: 10418991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.
    Reis SL; Abdo CH
    Clinics (Sao Paulo); 2014; 69(4):294-303. PubMed ID: 24714838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of testosterone in the treatment of hypoactive sexual desire disorder.
    Schwenkhagen A; Studd J
    Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the rationale for androgen therapy for women?
    Papalia MA; Davis SR
    Treat Endocrinol; 2003; 2(2):77-84. PubMed ID: 15871544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen status in healthy premenopausal women with loss of libido.
    Nyunt A; Stephen G; Gibbin J; Durgan L; Fielding AM; Wheeler M; Price DE
    J Sex Marital Ther; 2005; 31(1):73-80. PubMed ID: 15841707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of androgens in female sexual dysfunction.
    Shifren JL
    Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S19-24. PubMed ID: 15065634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results.
    Munarriz R; Talakoub L; Flaherty E; Gioia M; Hoag L; Kim NN; Traish A; Goldstein I; Guay A; Spark R
    J Sex Marital Ther; 2002; 28 Suppl 1():165-73. PubMed ID: 11898698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgenic hormones and aging--the link with female sexual function.
    Davison SL; Davis SR
    Horm Behav; 2011 May; 59(5):745-53. PubMed ID: 21215268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues.
    Warnock JK; Bundren JC; Morris DW
    Psychopharmacol Bull; 1997; 33(4):761-6. PubMed ID: 9493489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.